tiprankstipranks

A S Novo Insider Profile

18 Followers
A S Novo, Ten Percent Owner at IVERIC bio, holds 1.74M shares in Metagenomi, Inc. (Ticker: MGX), holds 5.09M shares in IO Biotech (Ticker: IOBT), holds 3.52M shares in Cyteir Therapeutics (Ticker: CYT).
tipranks
A S Novo

A S Novo
IVERIC bio (ISEE)
Ten Percent Owner

Ranked #83,727 out of 97,489 Corporate Insiders

Profitable Transactions

42%
32 out of 76 Profitable Transactions

Average Return

-6.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1B
23.47%
12.38%
10.58%
9.15%
44.41% Others
A breakdown of A S Novo's holdings

Insider Roles

Arcellx Inc
(ACLX)
Ten Percent Owner
Harmony Biosciences Holdings
(HRMY)
Ten Percent Owner
Praxis Precision Medicines
(PRAX)
Ten Percent Owner
Morphic Holding
(MORF)
Ten Percent Owner
+23 other positions
Roles that A S Novo holds in companies

Most Profitable Insider Trade

Stock:
Alder Biopharmaceuticals
(ALDR)
Rating:Informative Buy
Date:May 13, 2014 - May 13, 2015
Return:+241.70%
The most profitable trade made by A S Novo

A S Novo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ISEE
IVERIC bio
Dec 16, 2016
Informative Sell
17.59M
$196.17M
KalVista Pharmaceuticals
Oct 12, 2017
Ten Percent Owner
Informative Sell
26.27M
$41.03M
APEN
Apollo Endosurgery
Jul 26, 2017
Informative Sell
345.66K
$14.57M
Corvus Pharmaceuticals
Jul 09, 2020
Ten Percent Owner
Informative Sell
8.16M
$3.03M
ETTX
Entasis Therapeutics Holdings
Oct 01, 2018
Uninformative Buy
$4.78M
Milestone Pharmaceuticals
Nov 27, 2019
SEE REMARKS, Ten Percent Owner
Informative Sell
3.84M
$3.92M
Morphic Holding
Jul 01, 2019
Ten Percent Owner
Uninformative Buy
$104.57M
Mirum Pharmaceuticals
Jul 23, 2019
Ten Percent Owner
Informative Buy
8.63M
$71.57M
Galera Therapeutics
Feb 19, 2021
Ten Percent Owner
Informative Sell
5.29M
$572.95K
Nkarta
Jul 16, 2020
Ten Percent Owner
Uninformative Buy
$35.87M
Inozyme Pharma
Feb 01, 2021
Ten Percent Owner
Informative Sell
7.88M
$14.37M
CMPI
Checkmate Pharmaceuticals
Feb 25, 2022
Informative Sell
23.02K
$22.70M
Harmony Biosciences Holdings
Aug 25, 2020
Ten Percent Owner
Informative Buy
3.18M
$141.60M
Spruce Biosciences
Feb 21, 2023
Ten Percent Owner
Informative Buy
7.00M
$35.43M
Praxis Precision Medicines
Oct 21, 2020
Ten Percent Owner
Uninformative Buy
$120.98M
Aligos Therapeutics
Oct 22, 2020
Ten Percent Owner
Informative Buy
3.00M
$2.95M
EAR
Eargo
Oct 22, 2020
Informative Buy
2.70M
$2.28M
Galecto
Nov 04, 2020
Ten Percent Owner
Informative Buy
5.00M
$2.05M
Edgewise Therapeutics
Sep 16, 2022
Ten Percent Owner
Informative Buy
5.00M
$101.34M
Reneo Pharmaceuticals
Jun 23, 2023
Ten Percent Owner
Informative Sell
709.00K
$5.46M
Verve Therapeutics
Jun 22, 2021
Ten Percent Owner
Uninformative Buy
$12.92M
Cyteir Therapeutics
Jul 20, 2023
Ten Percent Owner
Informative Sell
280.24K
$10.92M
Minerva Surgical
Oct 27, 2021
Ten Percent Owner
Uninformative Buy
$1.07M
IO Biotech
Feb 13, 2024
Ten Percent Owner
Informative Sell
988.21K
$8.96M
Arcellx Inc
Feb 09, 2022
Ten Percent Owner
Informative Buy
12.50M
$268.41M
Bolt Biotherapeutics
Jul 15, 2022
Ten Percent Owner
Informative Sell
1.60M
$4.48M
Disc Medicine
Jun 28, 2023
Ten Percent Owner
Informative Sell
57.63M
$82.16M
Metagenomi, Inc.
Feb 15, 2024
Ten Percent Owner
Uninformative Buy
$20.87M
TBRA
Tobira Therapeutics
Jul 13, 2016
Informative Sell
709.76K
$104.02M
FLXN
Flexion Therapeutics
Jun 22, 2015
Informative Sell
3.09M
$19.45M
CLCD
CoLucid Pharmaceuticals
Sep 13, 2016
Informative Buy
2.00M
$142.21M
HTG Molecular Diagnostics
Aug 25, 2017
Ten Percent Owner
Informative Sell
2.08M
$435.26K
Inogen
Jun 03, 2021
Ten Percent Owner
Informative Sell
38.98M
$14.61M
ALDR
Alder Biopharmaceuticals
May 13, 2014
Uninformative Buy
$60.44M
Nevro Corp
Nov 13, 2014
SEE REMARKS, Ten Percent Owner
Uninformative Buy
$31.21M
ZSPH
ZS Pharma
Jun 23, 2014
Uninformative Buy
$70.34M
OTIC
Otonomy
Aug 20, 2014
Informative Buy
243.04K
$250.13K
Akebia Therapeutics
Mar 26, 2014
SEE REMARKS, Ten Percent Owner
Uninformative Buy
$2.59M
BMTI
Biomimetic Therapeutics
List of latest transactions for each holding click on a transaction to see A S Novo's performance on stock

A S Novo insider profile FAQ

What is the percentage of profitable transactions made by A S Novo?
The percentage of profitable transactions made by A S Novo is 42%.
    What is the average return per transaction made by A S Novo?
    The average return per transaction made by A S Novo is -6.60%.
      What stocks does A S Novo hold?
      A S Novo holds: ISEE, KALV, APEN, CRVS, ETTX, MIST, MORF, MIRM, GRTX, NKTX, INZY, CMPI, HRMY, SPRB, PRAX, ALGS, EAR, GLTO, EWTX, RPHM, VERV, CYT, UTRS, IOBT, ACLX, BOLT, IRON, MGX, TBRA, FLXN, CLCD, HTGMQ, INGN, ALDR, NVRO, ZSPH, OTIC, AKBA, BMTI stocks.
        What was A S Novo’s latest transaction?
        A S Novo latest transaction was an Uninformative Buy of ―.
          What was A S Novo's most profitable transaction?
          A S Novo’s most profitable transaction was an Informative Buy of ALDR stock on May 13, 2014. The return on the trade was 241.70%.
            What is A S Novo's role in IVERIC bio?
            A S Novo's role in IVERIC bio is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.